England will be the first country in the world to begin vaccinating people with sexually transmitted infections of gonorrhea.

It won't work for everyone. The focus will be on homosexual and bisexual men with multiple sexual partners or a history of sexually transmitted infections.

The vaccine is 30-40% effective, but NHS England hopes it will reverse a large number of infections.

There were more than 85,000 cases in 2023, the highest case since it began recording in 1918.

Gonorrhea is not always symptomatic, but they can include pain, abnormal excretion, inflammation of the genitals, and infertility.

How many people choose to be immune is uncertain.

But the predictions from Imperial College London show that if the jab proves to be popular, it can prevent 100,000 cases and save nearly £8 million in the NHS over the next decade.

Sexual health exerciser Max told BBC Newsbeat that he will be "100%" vaccinated after being diagnosed with gonorrhea twice in a year.

“I think it’s great,” he said, adding: “It’s going to put pressure on the clinic, it’s a huge win.”

Vaccination will begin in August and will be provided through sexual health services.

Scottish Public Health says it is also working to launch its own plans for high-risk individuals.

The BBC Newsbeat asked health agencies in Wales and Northern Ireland if they intend to do so.

This vaccine is not designed for gonorrhea. This is the meningitis B vaccine currently given to babies.

But the bacteria that cause both diseases are so close that Menb pricks appear to have reduced gonorrhea cases by one third.

This will require subtle conversations at the sexual health clinic, as the vaccine will not eliminate the risk of capturing gonorrhea. Usually, it is caught without a condom.

But Professor Andrew Pollard, chairman of the Joint Committee on Vaccination and Immunization for Recommended Vaccines, said that while it is only 30% effective, it is "worthy" and could have "a huge impact" overall.

The decision not only deals with the number of records in the case. Gonorrhea is becoming increasingly difficult to treat.

Most cases are treated with single doses of antibiotics, but have an 80-year history of bacteria, which has led to repeated development of gonorrhea's resistance to our antibiotics.

Currently treatment is also happening, which is why some doctors are worried that gonorrhea may not be treated in one day.

The best way to deal with a drug-resistant infection is to not catch it first.

Dr Amanda Doyle from NHS England said: “Goglycopy is a big step in sexual health and is crucial to protecting individuals, helping to prevent the spread of infection and reduce the growth rate of bacterial antibiotics.”

People who are most affected by gonorrhea in the UK are gay and bisexual men aged 16 to 25, as well as people of black and Caribbean descent.

When offered primarily to gay and bisexual men rather than all teenagers, the vaccine is priced at about £8 per dose, which is the value of value.

But clinicians are indeed free to use their own judgment and provide vaccines to people using sexual health services they believe are equally high-risk.

People will be provided with MPOX (formerly Monkeypox), HPV and hepatitis vaccines at the same time.

Professor Matt Phillips, president of the British Association for Sexual Health and HIV, said: “This is good news for sexual health and wellness in England and a landmark moment.

“The diagnosis of gonorrhea has been the highest since the start of the record, which has the potential to help us solve this problem.”

It is not yet known how long the protection provided by the vaccine will last, or the frequency of jabs may need to be enhanced.

The decision came nearly a year and a half after the UK's JCVI recommended the vaccination program.

Sexual health exercisers criticized the wait for so long, but welcomed the decision.

Katie Clark, head of policy and advocacy at Terrance Higgins Trust, called it a “huge victory.”

Live Live Live Live at 12:45 and 17:45 on weekdays - or listen here.